Gram-negative: ensuring board assurance against national standards

An event for board members and executives in the NHS to hear from national leaders how to assess performance and assurance against national standards for Gram-negative bloodstream infections.

With the national ambition to reduce Gram-negative bloodstream infections in half by 2021, it’s essential that NHS board members can assure themselves that their trust is meeting relevant standards, and contributing to a local system-wide approach to reducing healthcare associated infections.

At this event you will:

  • Hear why we’ve included a reduction in E.coli infections to our single oversight framework
  • Hear about the impact reducing such infections can have on patients’ quality of life, and the wider benefits for your trust by avoiding further complications
  • Find out the questions you should be asking and how to interpret data to assure yourself and the board that your trust is improving infection rates
  • Learn what support NHS Improvement and NHS England can provide to help you meet these targets, including a new collaborative
  • Discuss issues with other board members from trusts and STP leads, and think about local system solutions

We’ll be featuring trusts who have made improvement in their infection rates, and sharing the learning from what’s worked, and what’s not. 

Who should attend?

From NHS organisations:

  • STP leaders
  • Chief executives
  • Chairs
  • Directors of nursing
  • Medical directors
  • Non-executive directors responsible for quality
  • Accountable officers of clinical commissioning groups

If you have any questions about this event, please email

Is there anything wrong with this page?

Help us improve this website

Do not include any personal, sensitive or confidential information.